Company: GLPG
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001558370-25-003806
Chunk: 198

Company: GALAPAGOS NV
Filing Date: 2025-03-27
Form: 20-F
Item: Item 5
Chunk 198
---
203%    
​
​
Costs increased by €11.5 million in 2024 explained by higher personnel expenses related to strategic marketing in oncology. Impairment in 2024 refers to a bad debt provision of €4.0 million for a disputed invoice.

​
144

General and administrative expenses
The following table summarizes our general and administrative expenses for the years ended December 31, 2024 and 2023, together with the changes to those items.

                    ​                       ​    ​         ​         ​       ​         ​       ​   ​      ​    
---------------------------------------------------------------------------------------------------------------
​                                           ​   Year ended December 31,                        ​   ​          ​
​                                           2024                   2023                            ​   % Change
​                                           ​   ​                       (Euro, in thousands)   ​   ​          ​
Personnel costs                             ​   €       (52,642)   ​       €        (66,098)   ​   ​      (20%)
Depreciation and impairment                 ​   ​        (8,697)   ​       ​        (15,978)   ​   ​      (46%)
Legal and professional fees                 ​   ​       (33,960)   ​       ​        (23,250)   ​   ​        46%
Other operating expenses                    ​   ​       (21,946)   ​       ​        (22,963)   ​   ​       (4%)
Total general and administrative expenses   ​   €      (117,245)   ​       €       (128,289)   ​   ​       (9%)
​
​
The decrease in our general and administrative expenses in 2024 was mainly explained by a decrease in personnel expenses primarily due to lower accelerated non-cash cost recognition for our subscription right plans related to good leavers and reduced severance costs. Impairment expenses decreased as we recorded an impairment in 2023 of €7.6 million on the construction project in Mechelen (Belgium). The increase in legal and professional fees mainly related to business development activities and corporate projects.
Other operating income
The following table summarizes our other operating income for the years ended December 31, 2024 and 2023, together with the changes to those items.

             ​                 ​    ​       ​       ​      ​       ​      ​   ​      ​    
------------------------------------------------------------------------------------------
​                              ​   Year ended December 31,                ​   ​   ​